Fundraising Fox

Gabriel Ocana Santero

Founder

Founder at Exin Therapeutics

South San Francisco, California, United States

FoundedExin Therapeutics · YC

About

Gabriel Ocana Santero holds an MSc in Neuroscience and PhD in Pharmacology from Oxford University, with research experience spanning gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. He has conducted work on neurodevelopment and serotonin signaling at the Gatsby Unit at UCL, and now develops gene therapies for neurological conditions at Exin Therapeutics.

LinkedIn ↗X / Twitter ↗
Latest on 𝕏

Gabriel Ocana-Santero @ocanasantero

📖 Full paper: https://t.co/7kWQm7R0IO 💬 Questions or thoughts? Let us know! 🙌 #Neuroscience #Serotonin #BrainDevelopment

Dec 14, 2024 · ♥ 6 · ⇄ 1

Gabriel Ocana-Santero @ocanasantero

9/ This work from @Interneuron_Dev lab is a collaboration with the sharp and @paqio labs. Thanks to all co-authors, particularly @WarmingHannah for all the ex vivo results, to @yulonglilab for providing the 5-HT sensor and to @Serotonin_h2020 for funding the project!!! https://t.co/y5krN515rl

Dec 14, 2024 · ♥ 3

Gabriel Ocana-Santero @ocanasantero

8/ Our work underscores the importance of serotonin regulation in early life, shaping brain circuits for a lifetime. 🎢

Dec 14, 2024 · ♥ 1

Founder at Exin TherapeuticsYC W25

Intro paths

YC

Gabriel went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.

GP

Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Exin Therapeutics's batch and knows the company first-hand. YC profile ↗

→

In turn, Gabriel can intro founders to Exin Therapeutics's investors below.

Exin Therapeutics's investors · 2

468 CapitalY Combinator

Co-founders at Exin Therapeutics

MTMarko Tvrdic
Marko TvrdicFounder
IA
Ivan Alex Priela LazarteExecutive Officer, Director

Experience

  1. Exin TherapeuticsCEO and Co-foundercurrent2025 — presentSan Francisco Bay Area
  2. Serotonin and BEYONDSerotonin and Beyond Early Stage Researcher2021 — 2024Oxford, England, United Kingdom
  3. Gatsby Computational Neuroscience UnitNeuroAI Research Internship2023Greater London, England, United Kingdom
  4. Fundación "la Caixa"Postgraduate Studies' Fellowship Holder2020 — 2021Oxford, England, United Kingdom
  5. Centro de Biología Molecular Severo Ochoa, CBMSOResearch Intern2020Greater Madrid Metropolitan Area
  6. Karolinska InstitutetResearch Intern2019Greater Stockholm Metropolitan Area
  7. Medical University of ViennaResearch Intern2018Austria

Education

  1. University of OxfordDoctor of Philosophy - PhD, Pharmacology
  2. Y CombinatorW25, Biotechnology2025
  3. University of OxfordMaster of Science - MS, Neuroscience
  4. Boston UniversityBachelor of Science - BS, Neuroscience
  5. Universidad Autónoma de MadridBachelor of Science - BS, Biochemistry

Skills & more

Python (Programming Language)Machine LearningArtificial Neural NetworksInvestigaciónDocenciaAptitudes de laboratorioCancer ResearchLeadership

Languages English · French · Spanish

  • The Science and Business of Biotechnology — MITx Courses
  • TOEFL-ibt (113/120) — TOEFL

From Gabriel's professional profile.

Same school

Also attended University of Oxford745

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 739 more

Also attended Y Combinator1,463

Akshat GoenkaInvestor at Moonfire VenturesJon XuGeneral Partner at Y CombinatorTed ChaiAssociate at Scale Venture PartnersLeo LuInvestor at Foundation CapitalMaroof AhmedFounder at Octopus VenturesYusuf SherwaniCo-Founder and CEO at Pelago; a Londoner living in New York City

+ 1,457 more

Also attended Boston University204

Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder CollectiveKatherine OgnibeneOperations Associate at Founder Collective

+ 198 more

Also attended Universidad Autónoma de Madrid52

Borja FernándezGeneral Partner at Inveready Technology Investment GroupAna MartínezGeneral Partner at Inveready Technology Investment GroupMiguel Garcia DiazVice President for Research, Scholarship and Innovation at University of Delaware at The Innovation SpaceRyan GembalaFounder & Managing Partner at Pathbreaker VenturesCristina GarmendiaGeneral Partner at Ysios CapitalAlmudena MéndezAssociate at Ysios Capital

+ 46 more

Shared employers

Also worked at Exin Therapeutics1

Marko TvrdicFounder at Exin Therapeutics

Also worked at Fundación "la Caixa"2

Arturo UrriosPartner at Ysios CapitalSebastián ChiavennaPrincipal at Criteria Bio Ventures

Also worked at Karolinska Institutet14

Gunnar AhlbergVenture Partner at ScietyJohan LundVenture Partner at ScietyJonathan IlickiInvestor at IndustrifondenChristian Krog-JensenInvestor at Almi InvestCarl KilanderPartner at HealthCapAaron NelsonManaging Director at Novartis Venture Fund

+ 8 more

Also worked at Medical University of Vienna2

Christian MandlSenior Advisor at Adjuvant CapitalChristoph HuberAdvisory Board at Onsight Ventures